Descriptive characteristics of the study population according to sex, Zwyat Razin, 2003
| Males (n = 309) | Females (n = 456) | |
|---|---|---|
| BMI, body mass index; DBP, diastolic blood pressure; HCV, hepatitis C virus; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; WHR, waist hip ratio. | ||
| Descriptive characteristics (n (%)) | ||
| Age group (y) | ||
| 25–34 | 93 (30.1) | 131 (28.7) |
| 35–44 | 83 (26.9) | 138 (30.3) |
| 45–54 | 61 (19.7) | 95 (20.8) |
| 55–64 | 34 (11.0) | 60 (13.2) |
| ⩾65 | 38 (12.3) | 32 (7.0) |
| HCV infection status | ||
| Never infected | 224 (72.5) | 361 (79.2) |
| Past infection | 22 (7.1) | 45 (9.9) |
| Chronic infection | 63 (20.4) | 50 (11.0) |
| Clinical examination (mean (SD)) | ||
| Height (cm) | 167.9 (7.0) | 155.1 (6.4) |
| Weight (kg) | 72.5 (13.8) | 69.7 (15.9) |
| BMI (kg/m2) | 25.7 (4.5) | 28.9 (6.3) |
| Waist circumference (cm) | 86.5 (12.3) | 90.3 (14.6) |
| WHR | 0.90 (0.08) | 0.88 (0.08) |
| SBP (mm Hg) | 124.6 (19.8) | 124.6 (22.5) |
| DBP (mm Hg) | 80.7 (10.7) | 80.6 (12.3) |
| Metabolic variables (mean (SD)) | ||
| Fasting glucose (mg/dl) | 85.5 (22.5) | 88.3 (33.0) |
| Total cholesterol (mg/dl) | 171.6 (37.8) | 183.8 (41.0) |
| LDL cholesterol (mg/dl) | 104.2 (34.7) | 110.4 (37.4) |
| HDL cholesterol (mg/dl) | 42.8 (9.0) | 50.0 (11.6) |
| Triglycerides (mg/dl) | 123.4 (62.6) | 117.5 (64.9) |
| Current treatments (n (%)) | ||
| Antihypertensive drugs | 24 (7.8) | 52 (11.4) |
| Oral antidiabetic drugs | 8 (2.6) | 16 (3.5) |
| Insulin | 3 (1.0) | 3 (0.7) |
| Cholesterol lowering drugs | 1 (0.3) | 3 (0.7) |